The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent hereditary angioedema attacks in children aged 2 to under 12, the company ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

Pharmacokinetic and safety studies were analyzed to demonstrate the safety and efficacy of TRN-257, as well as previous research on oxybate products.

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

Dublin, Aug. 17, 2017 (GLOBE NEWSWIRE) -- The "Deuterated Drugs Formulations Therapeutics Markets Strategies" report has been added to Research and Markets' offering. Deuterated Drugs: Products, ...

Pharmacy is the drug developer, overseeing clinical studies and formulation. Check the NIRF 2025 ranking of the best pharmacy ...